CAS 170111-28-1

N-((S)-4-Methyl-1-oxo-1-(((S,E)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl)amino)pentan-2-yl)morpholine-4-carboxamide

CAS : 170111-28-1

N-((S)-4-Methyl-1-oxo-1-(((S,E)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl)amino)pentan-2-yl)morpholine-4-carboxamide

Degré de pureté : 99% 98%ee

Masse moléculaire : 527.69g/mol

Ref: 54-OR1074677

LHVS

CAS : 170111-28-1

LHVS is a small-molecule inhibitor, synthesized for biological research, known to target protease activity. Derived from advanced chemical synthesis techniques, it serves as a potent inhibitor with specificity for lysosomal enzymes. Its mechanism of action involves the covalent modification of the active-site cysteines in proteases, effectively inhibiting their enzymatic function. By blocking these critical enzymes, LHVS disrupts protein processing and turnover within cellular environments. This makes it a valuable tool in studying autophagic and lysosomal degradation pathways, contributing to a deeper understanding of cellular homeostasis and related disorders. Researchers utilize LHVS to dissect molecular pathways in various disease models, including cancer and neurodegeneration, where protease activity and protein degradation are dysregulated.

Formule : C₂₈H₃₇N₃O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 527.7 g/mol

Ref: 3D-VGA11128

LHVS

CAS : 170111-28-1

LHVS effectively blocks T.

Formule : C₂₈H₃₇N₃O₅S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 527.68

Ref: TM-T11846